197 - Host-Directed Therapy: Mechanisms and Infectious Complications

Saturday, October 19, 2024

10:30 AM – 11:45 AM US PT

Location: 515 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

MD

Mahalia Dessruisseaux
Luiz Bermudez, MD

Professor
Oregon State University
Corvallis, OR, United States

Faculty(s)

Alexis Kaushansky, PhD (she/her/hers)

Associate Professor
University of Washington / Seattle Children's
WB

William Bishai
DB

Derek Bays, MD (he/him/his)

Assistant Professor
Internal Medicine
UC Davis Health
Sacramento, California, United States

Disclosure(s):

Mahalia Dessruisseaux: No financial relationships to disclose

Luiz Bermudez, MD: No financial relationships to disclose

Alexis Kaushansky, PhD: No financial relationships to disclose

Derek J. Bays, MD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the use of the host defense to address malaria;
explain new strategies to treat tb;
describe updates about the host mechanisms associated with anti-fungal defense;
identify individualized therapeutics.

Presentations:

10:55 AM – 11:20 AM US PT

The Use of Host-Directed Therapy to Address Tuberculosis
Speaker: William Bishai
11:20 AM – 11:45 AM US PT

Host-Directed Therapy in Fungal Diseases
Speaker: Derek J. Bays, MD (he/him/his) – UC Davis Health
11:30 AM – 10:55 AM US PT

Host-Directed Interventions Against Malaria
Speaker: Alexis Kaushansky, PhD (she/her/hers) – University of Washington / Seattle Children's